152 related articles for article (PubMed ID: 33794821)
1. Cervical cancer screening patterns among HIV-positive women in Estonia: a population-based retrospective cohort study.
Tisler A; Ojavee SE; Veerus P; Soodla P; Uusküla A
BMC Cancer; 2021 Apr; 21(1):350. PubMed ID: 33794821
[TBL] [Abstract][Full Text] [Related]
2. Effect of Pap-smear and sociodemographic factors on cervical cancer risk in Estonia: A population-based case-control study.
Nõmm O; Veerus P; Orumaa M; Innos K
Cancer Epidemiol; 2022 Oct; 80():102231. PubMed ID: 35901623
[TBL] [Abstract][Full Text] [Related]
3. Impact of immunosuppression and region of birth on risk of cervical intraepithelial neoplasia among migrants living with HIV in Sweden.
Carlander C; Wagner P; Svedhem V; Elfgren K; Westling K; Sönnerborg A; Sparén P
Int J Cancer; 2016 Oct; 139(7):1471-9. PubMed ID: 27177207
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and distribution of cervical high-risk human papillomavirus and cytological abnormalities in women living with HIV in Denmark - the SHADE.
Thorsteinsson K; Storgaard M; Katzenstein TL; Ladelund S; Rønsholt FF; Johansen IS; Pedersen G; Hashemi L; Nielsen LN; Nilas L; Obel N; Bonde J; Lebech AM
BMC Cancer; 2016 Nov; 16(1):866. PubMed ID: 27821088
[TBL] [Abstract][Full Text] [Related]
5. Adherence to the cervical cancer screening program in women living with HIV in Denmark: comparison with the general population.
Thorsteinsson K; Ladelund S; Jensen-Fangel S; Katzenstein TL; Johansen IS; Pedersen G; Junge J; Helleberg M; Storgaard M; Lebech AM
BMC Infect Dis; 2014 May; 14():256. PubMed ID: 24885577
[TBL] [Abstract][Full Text] [Related]
6. Incidence of cervical dysplasia and cervical cancer in women living with HIV in Denmark: comparison with the general population.
Thorsteinsson K; Ladelund S; Jensen-Fangel S; Katzenstein TL; Johansen IS; Pedersen G; Junge J; Helleberg M; Storgaard M; Obel N; Lebech AM
HIV Med; 2016 Jan; 17(1):7-17. PubMed ID: 26058995
[TBL] [Abstract][Full Text] [Related]
7. High-risk human papillomavirus prevalence in self-collected cervicovaginal specimens from human immunodeficiency virus (HIV)-negative women and women living with HIV living in Botswana.
Castle PE; Varallo JE; Bertram MM; Ratshaa B; Kitheka M; Rammipi K
PLoS One; 2020; 15(2):e0229086. PubMed ID: 32053659
[TBL] [Abstract][Full Text] [Related]
8. Impact of healthcare access and HIV testing on utilisation of cervical cancer screening among US women at high risk of HIV infection: cross-sectional analysis of 2016 BRFSS data.
Zhang D; Advani S; Huchko M; Braithwaite D
BMJ Open; 2020 Jan; 10(1):e031823. PubMed ID: 31911515
[TBL] [Abstract][Full Text] [Related]
9. Support for lowering cervical cancer screening age to 25 for women living with HIV: retrospective cross-sectional programmatic data from Botswana.
Ramogola-Masire D; Grover S; Mathoma A; Monare B; Gabaitiri L; Bazzett-Matabele L; Hofmeyr G; Morroni C; Luckett R
BMC Womens Health; 2022 Apr; 22(1):100. PubMed ID: 35366863
[TBL] [Abstract][Full Text] [Related]
10. Upscaling cervical cancer screening and treatment for women living with HIV at a rural referral hospital in Tanzania: protocol of a before-and-after study exploring HPV testing and novel diagnostics.
Di Salvo I; Mnzava D; Nicoletti GJ; Senkoro E; Ndege RC; Huang DJ; Makunja NT; Kassiga GI; Kaufmann AM; Weisser M; Kind AB
BMC Health Serv Res; 2023 Mar; 23(1):234. PubMed ID: 36894985
[TBL] [Abstract][Full Text] [Related]
11. Lifetime prevalence and adherence rate of cervical cancer screening among women living with HIV: a systematic review and meta-analysis.
Gao X; Zhang W; Sun J; Adeloye D; Jin H; Rudan I; Song P; Jin M
J Int AIDS Soc; 2023 May; 26(5):e26090. PubMed ID: 37247380
[TBL] [Abstract][Full Text] [Related]
12. Cervical human papillomavirus DNA detection in women living with HIV and HIV-uninfected women living in Limbe, Cameroon.
Adedimeji A; Ajeh R; Dzudie A; Kendowo E; Fuhngwa N; Nsame D; Simo-Wambo AG; Orock E; Hebert TM; Pierz AJ; Murokora D; Anastos K; Castle PE
J Clin Virol; 2020 Jul; 128():104445. PubMed ID: 32470891
[TBL] [Abstract][Full Text] [Related]
13. A comparison of high-grade cervical abnormality risks in women living with and without human immunodeficiency virus undergoing routine cervical-cancer screening.
Castle PE; Befano B; Schiffman M; Wentzensen N; Lorey T; Poitras N; Hyer M; Cheung LC
Prev Med; 2022 Sep; 162():107157. PubMed ID: 35810936
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and predictors of cervical cancer screening among HIV-positive women in rural western Uganda: insights from the health-belief model.
Vigneshwaran E; Goruntla N; Bommireddy BR; Mantargi MJS; Mopuri B; Thammisetty DP; Veerabhadrappa KV; Bukke SPN
BMC Cancer; 2023 Dec; 23(1):1216. PubMed ID: 38066496
[TBL] [Abstract][Full Text] [Related]
15. Cervical cancer screening uptake among HIV-positive women in Ontario, Canada: A population-based retrospective cohort study.
Burchell AN; Kendall CE; Cheng SY; Lofters A; Cotterchio M; Bayoumi AM; Glazier RH; Antoniou T; Raboud J; Yudin MH; Loutfy M
Prev Med; 2018 Feb; 107():14-20. PubMed ID: 29197533
[TBL] [Abstract][Full Text] [Related]
16. Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020-99: a modelling study.
Simms KT; Steinberg J; Caruana M; Smith MA; Lew JB; Soerjomataram I; Castle PE; Bray F; Canfell K
Lancet Oncol; 2019 Mar; 20(3):394-407. PubMed ID: 30795950
[TBL] [Abstract][Full Text] [Related]
17. Elimination of cervical cancer in Tanzania: Modelled analysis of elimination in the context of endemic HIV infection and active HIV control.
Hall MT; Smith MA; Simms KT; Barnabas R; Murray JM; Canfell K
Int J Cancer; 2021 Jul; 149(2):297-306. PubMed ID: 33634857
[TBL] [Abstract][Full Text] [Related]
18. Persistence of cervical high-risk human papillomavirus in women living with HIV in Denmark - the SHADE.
Thorsteinsson K; Ladelund S; Storgaard M; Katzenstein TL; Johansen IS; Pedersen G; Rönsholt FF; Nielsen LN; Nilas L; Franzmann M; Obel N; Lebech AM; Bonde J
BMC Infect Dis; 2019 Aug; 19(1):740. PubMed ID: 31438877
[TBL] [Abstract][Full Text] [Related]
19. "HIV is not an easily acceptable disease": the role of HIV-related stigma in obtaining cervical cancer screening in India.
Gordon JR; Barve A; Chaudhari V; Kosambiya JK; Kumar A; Gamit S; Wells KJ
Women Health; 2019 Aug; 59(7):801-814. PubMed ID: 30714510
[TBL] [Abstract][Full Text] [Related]
20. Cervical precancer and cancer incidence among insured women with and without HIV in South Africa.
Fernández Villalobos NV; Ruffieux Y; Haas AD; Chinogurei C; Cornell M; Taghavi K; Egger M; Folb N; Maartens G; Rohner E
Int J Cancer; 2024 Jan; 154(2):273-283. PubMed ID: 37658695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
